Intrinsic Value of S&P & Nasdaq Contact Us

Incyte Corporation INCY NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
82/100
6/7 Pass
SharesGrow Intrinsic Value
$117.61
+20.4%
Analyst Price Target
$108.90
+11.5%

Incyte Corporation (INCY) has a consensus analyst rating of Buy, based on 44 analysts covering the stock. Of those, 24 recommend buying, 18 recommend holding, and 2 recommend selling.

The analyst consensus price target for INCY is $108.90, representing a +11.5% upside from the current price of $97.69. Price targets range from a low of $84.00 to a high of $135.00.

Analyst Consensus — INCY

Buy
Strong Buy
0
Buy
24
Hold
18
Sell
2
Strong Sell
0
44 analysts
Price Targets
Consensus$108.90
High$135.00
Low$84.00
Median$108.50
Last Month Avg-
Last Quarter Avg$112.13
Last Year Avg$103.57
All-Time Count48
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message